We also confirm highly significant phenotypic differences in these two types of ameloblastomas as BRAF-mutant cases occurred preferentially in the mandible and at a much younger age (mean age 42 years) than SMO-mutant cases occurring preferentially in the maxilla at an older age (mean age 67 years). This evidence concerns the gene BRAF and ameloblastoma.